Khoshhali Mehri, Kazemi Iraj, Hosseini S Mohsen, Seirafian Shiva
Student Research Center, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran.
Kidney Res Clin Pract. 2017 Jun;36(2):182-191. doi: 10.23876/j.krcp.2017.36.2.182. Epub 2017 Jun 30.
In peritoneal dialysis, technique failure is an important metric to be considered. This study was performed in order to identify the relationship between trajectories of serum albumin levels and peritoneal dialysis technique failure on end-stage renal disease patients according to diabetic status. Furthermore, this study was performed to reveal predictors of serum albumin and technique failure simultaneously.
This retrospective cohort study included 300 (189 non-diabetic and 111 diabetic) end-stage renal disease patients on continuous ambulatory peritoneal dialysis treated in Al-Zahra Hospital, Isfahan, Iran, from May 2005 to March 2015. Bayesian joint modeling was carried out in order to determine the relationship between trajectories of serum albumin levels and peritoneal dialysis technique failure in the patients according to diabetic status. Death from all causes was considered as a competing risk.
Using joint modeling approach, a relationship between trajectories of serum albumin with hazard of transfer to hemodialysis was estimated as -0.720 (95% confidence interval [CI], -0.971 to -0.472) for diabetic and -0.784 (95% CI, -0.963 to -0.587) for non-diabetic patients. From our findings it was showed that predictors of low serum albumin over time were time on peritoneal dialysis for diabetic patients and increase in age and time on peritoneal dialysis, history of previous hemodialysis, and lower body mass index in non-diabetic patients.
The results of current study showed that controlling serum albumin over time in non-diabetic and diabetic patients undergoing continuous ambulatory peritoneal dialysis treatment can decrease risk of adverse outcomes during the peritoneal dialysis period.
在腹膜透析中,技术失败是一个需要考虑的重要指标。本研究旨在根据糖尿病状态确定终末期肾病患者血清白蛋白水平轨迹与腹膜透析技术失败之间的关系。此外,本研究还旨在同时揭示血清白蛋白和技术失败的预测因素。
这项回顾性队列研究纳入了2005年5月至2015年3月在伊朗伊斯法罕的阿尔-扎赫拉医院接受持续性非卧床腹膜透析治疗的300例终末期肾病患者(189例非糖尿病患者和111例糖尿病患者)。采用贝叶斯联合模型来确定根据糖尿病状态患者血清白蛋白水平轨迹与腹膜透析技术失败之间的关系。将各种原因导致的死亡视为竞争风险。
采用联合模型方法,估计糖尿病患者血清白蛋白轨迹与转血液透析风险之间的关系为-0.720(95%置信区间[CI],-0.971至-0.472),非糖尿病患者为-0.784(95%CI,- 0.963至-0.587)。我们的研究结果表明,随着时间推移,糖尿病患者血清白蛋白水平低的预测因素是腹膜透析时间,非糖尿病患者血清白蛋白水平低的预测因素是年龄增加、腹膜透析时间、既往血液透析史和较低的体重指数。
本研究结果表明,在接受持续性非卧床腹膜透析治疗的非糖尿病和糖尿病患者中,随时间控制血清白蛋白水平可降低腹膜透析期间不良结局的风险。